Why the study?
Does metformin improve lipid metabolism and reverse the Warburg effect in a canine model of chronic atrial fibrillation?
Does metformin improve lipid metabolism and reverse the Warburg effect in a canine model of chronic atrial fibrillation?
In a preclinical canine model, metformin demonstrates potential anti-arrhythmic properties by attenuating atrial electrical and structural remodeling through metabolic regulation.
Answers are grounded in this paper and cite their sources.
Does not support metformin for AF remodeling in patients; extends preclinical metabolic findings but leaves clinical translation open.
Metformin improves lipid metabolism and reverses the Warburg effect in chronic AF via AMPK activation. It attenuates atrial electrical and structural remodeling.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: